Tadalafil/Finasteride

他达拉非/非那雄胺

Report date: 2026/03/16 20:01:47
NME

Base Information

Drug NameTadalafil/Finasteride
Drug Alias NameTadalafil/finasteride capsulesFinasteride/tadalafilTADFINEntadfiENTADFI +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitorsSteroid 5 alpha reductase inhibitors
TargetsPhosphodiesterase 5ASteroid 5 alpha reductase
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaProstatic Hyperplasia
Original Approved Country/TerritoryUnited States
Original Approved Date2021/12/09
Country/TerritoryUnited StatesMainland China
CombinationsYes TadalafilFinasteride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesVeru Inc
China Registration ClassN/A

Develop Information

Active CompaniesOnconetix Inc
Inactive CompaniesVeru Inc
Active IndicationsProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeG04CA
Related LinksN/A